Researchers in Canada can now get their sequence data before noon the following day
Louisville, KY (October 4, 2016). Eurofins MWG Operon LLC., a Eurofins Genomics company, one of the world leaders in genomics products and services, announces the launch of a new DNA sequencing Laboratory in Toronto, Ontario, CA. This new sequencing facility will provide fast, high-quality DNA sequencing services using the Sanger method to researchers all over Canada.
Overnight Sequencing is one of Eurofins Genomics’ signature services and has generated rapid growth and expansion in the US market. With the new Toronto-based laboratory, Eurofins’ will replicate the same model of success and speed. “This new DNA sequencing lab in Toronto is launched to directly address the growing needs of the scientific community in Canada. Through this new lab, we remain committed to delivering overnight DNA sequencing services, which our customers in the United States now enjoy, to researchers in the greater Toronto area and elsewhere in Canada.” said Martin Kunz, President of Eurofins MWG Operon LLC.
In addition to a full range of sequencing services, Canadians will receive bilingual support, both in English and French. “Researchers around the world know Eurofins Genomics as an American, European, or Asian company, but today, Eurofins Genomics is proud to be Canadian.” said Benjamin Senior, Manager, DNA Sequencing Business Unit. For more information about these and other services and solutions provided by Eurofins Genomics, logon to www.eurofinsgenomics.com.
About Eurofins MWG Operon LLC., a Eurofins Genomics Company
Eurofins MWG Operon LLC., a Eurofins Genomics company, is an international provider of DNA sequencing services, genotyping services, DNA synthesis products, and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. Besides this new lab, Eurofins Genomics operates leading R&D and production sites in the USA (Louisville, KY), Germany (Ebersberg, BY), India (Bengaluru, KA), and Japan (Tokyo).
The company's strengths are its customer focus, high quality genomics services, and fast turnaround times. Together with the international network of the Eurofins Group, Eurofins Genomics provides an outstanding team of experts and a broad range of technologies around the core business lines DNA & RNA oligonucleotides, custom DNA and next generation sequencing, gene synthesis and molecular biology, as well as genotyping and gene expression.
©Eurofins MWG Operon, LLC. A Eurofins Genomics Company